Andrew Emmett, Managing Director, Science & Regulatory Affairs, speaks about the important regulatory issues facing the industry, specifically PDUFA reauthorization, the FDA and regulation. Also, hear his programming highlights from the Achieving Regulatory Approval and Compliance Track at the upcoming 2012 BIO International Convention.
|
May 9, 2010
|
April 9, 2010
|
April 7, 2010
|
March 29, 2010
|
|
March 10, 2010
|
March 10, 2010
|
February 24, 2010
|
February 5, 2010
|